Hospital Universitario de la Princesa -ko ikertzaileekin lankidetzan egindako argitalpenak (43)

2024

  1. Bronchopulmonary colonization patterns in Spanish people with cystic fibrosis: Results of a national multicentre study

    Enfermedades Infecciosas y Microbiologia Clinica

  2. The cardiomyopathy of cystic fibrosis: a modern form of Keshan disease

    Frontiers in Cardiovascular Medicine, Vol. 11

2022

  1. Blood Neutrophil Counts Define Specific Clusters of Bronchiectasis Patients: A Hint to Differential Clinical Phenotypes

    Biomedicines, Vol. 10, Núm. 5

  2. Impact of Chronic Bronchial Infection by Staphylococcus aureus on Bronchiectasis

    Journal of Clinical Medicine, Vol. 11, Núm. 14

  3. Systemic Inflammatory Biomarkers Define Specific Clusters in Patients with Bronchiectasis: A Large-Cohort Study

    Biomedicines, Vol. 10, Núm. 2

  4. The Relation of CFTR-Genotype and Associated Comorbidities to Development of Pulmonary Atelectasis in Cystic Fibrosis Patients

    Archivos de Bronconeumologia, Vol. 58, Núm. 9, pp. 666-668

2021

  1. C-Reactive Protein Concentration in Steady-State Bronchiectasis: Prognostic Value of Future Severe Exacerbations. Data From the Spanish Registry of Bronchiectasis (RIBRON)

    Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 21-27

  2. Differences in nutritional status and inflammatory biomarkers between female and male patients with bronchiectasis: A large-cohort study

    Biomedicines, Vol. 9, Núm. 8

  3. Phenotypic clustering in non-cystic fibrosis bronchiectasis patients: The role of eosinophils in disease severity

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 16

  4. Pseudomonas aeruginosa and lung function decline in patients with bronchiectasis

    Clinical Microbiology and Infection, Vol. 27, Núm. 3, pp. 428-434

2020

  1. Erratum to Spanish Guidelines on the Evaluation and Diagnosis of Bronchiectasis in Adults [Arch Bronconeumol. 2018;54(2):79–87] (Archivos de Bronconeumologia (2018) 54(2) (79–87), (S0300289617302727), (10.1016/j.arbres.2017.07.015))

    Archivos de Bronconeumologia

  2. Impact of pseudomonas aeruginosa infection on patients with chronic inflammatory airway diseases

    Journal of Clinical Medicine, Vol. 9, Núm. 12, pp. 1-32

  3. Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial

    Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 162

  4. What Spanish consensus meant for the treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis in the initial lung infection?

    Medicina Clinica, Vol. 154, Núm. 6, pp. 232-235

2019

  1. Prognostic Value of Frequent Exacerbations in Bronchiectasis: The Relationship With Disease Severity

    Archivos de Bronconeumologia, Vol. 55, Núm. 2, pp. 81-87

2018

  1. Addition of hyaluronic acid improves tolerance to 7% hypertonic saline solution in bronchiectasis patients

    Therapeutic Advances in Respiratory Disease, Vol. 12

  2. Compassionate Use of Lumacaftor/Ivacaftor in Cystic Fibrosis: Spanish Experience

    Archivos de Bronconeumologia, Vol. 54, Núm. 12, pp. 614-618

  3. Compassionate Use of Lumacaftor/Ivacaftor in Cystic Fibrosis: Spanish Experience

    Archivos de Bronconeumologia, Vol. 54, Núm. 12, pp. 614-618

  4. Spanish Guidelines on Treatment of Bronchiectasis in Adults

    Archivos de Bronconeumologia, Vol. 54, Núm. 2, pp. 88-98

  5. Spanish Guidelines on the Evaluation and Diagnosis of Bronchiectasis in Adults

    Archivos de Bronconeumologia, Vol. 54, Núm. 2, pp. 79-87